with recent drug trials comming up negative my concern is gilead going forward.Do they have sufficiant revenue and pipeline to justify continued investment.Is this recent dip a buying opportunity ?
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Ma